AIM ImmunoTech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch AIM ImmunoTech and buy or sell other stocks, ETFs, and their options commission-free!

About AIMI

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. 

CEO
Thomas Kenwood Equels
CEOThomas Kenwood Equels
Employees
23
Employees23
Headquarters
Ocala, Florida
HeadquartersOcala, Florida
Founded
1966
Founded1966
Employees
23
Employees23

AIMI Key Statistics

Market cap
196.73K
Market cap196.73K
Price-Earnings ratio
-0.03
Price-Earnings ratio-0.03
Dividend yield
Dividend yield
Average volume
198.01K
Average volume198.01K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$35.96
52 Week high$35.96
52 Week low
$0.6141
52 Week low$0.6141

Stock Snapshot

The current AIM ImmunoTech(AIMI) stock price is $0.07, with a market capitalization of 196.73K. The stock trades at a price-to-earnings (P/E) ratio of -0.03.

During the trading day, AIM ImmunoTech(AIMI) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading volume for AIM ImmunoTech(AIMI) stock has reached 0, versus its average volume of 198.01K.

The stock's 52-week range extends from a low of $0.61 to a high of $35.96.

The stock's 52-week range extends from a low of $0.61 to a high of $35.96.

People also own

Based on the portfolios of people who own AIMI. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.